Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.41% is 53% below its 5-year average of 2.99%, near the low end of its 5-year range (-0.90%–7.35%).
271.05% above its 12-month average of 0.38%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.17%.
RETURN ON ASSETS (ROA)
1.41%
RETURN ON ASSETS (ROA) AVG TTM
0.38%
RETURN ON ASSETS (ROA) AVG 3Y
2.34%
RETURN ON ASSETS (ROA) AVG 5Y
2.99%
RETURN ON ASSETS (ROA) AVG 10Y
5.94%
RETURN ON ASSETS (ROA) AVG 15Y
5.38%
RETURN ON ASSETS (ROA) AVG 20Y
4.20%
CURRENT VS TTM AVG
+271.05%
CURRENT VS 3Y AVG
-39.81%
CURRENT VS 5Y AVG
-52.90%
CURRENT VS 10Y AVG
-76.28%
CURRENT VS 15Y AVG
-73.79%
CURRENT VS 20Y AVG
-66.43%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+104.37%
vs the sector median at left
Repligen Corporation
Market Cap
$10.08B
Return on Assets (ROA)
1.41%
TTM Avg
0.38%
3Y Avg
2.34%
5Y Avg
2.99%
Market Cap
$10.09B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.08B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.16B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.00B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.31B
Return on Assets (ROA)
-157.89%
TTM Avg
-89.00%
3Y Avg
-102.14%
5Y Avg
-97.13%
Market Cap
$10.37B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$9.65B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$10.54B
Return on Assets (ROA)
-7.29%
TTM Avg
-12.03%
3Y Avg
-16.66%
5Y Avg
-21.79%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Repligen Corporation (RGEN) | $10.08B | 1.41% | 0.38% | 2.34% | 2.99% |
| The Ensign Group, Inc. (ENSG)vs › | $10.09B | 6.59% | 6.34% | 6.05% | 6.29% |
| Molina Healthcare, Inc. (MOH)vs › | $10.08B | -0.04% | 5.29% | 6.08% | 6.13% |
| Align Technology, Inc. (ALGN)vs › | $10.16B | 6.44% | 6.68% | 6.69% | 12.75% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.00B | 2.17% | -6.26% | -11.14% | 1.46% |
| ImmunityBio, Inc. (IBRX)vs › | $10.31B | -157.89% | -89.00% | -102.14% | -97.13% |
| Globus Medical, Inc. (GMED)vs › | $10.37B | 9.76% | 6.05% | 5.92% | 6.23% |
| Henry Schein, Inc. (HSIC)vs › | $9.65B | 3.54% | 3.68% | 4.39% | 5.01% |
| 10x Genomics, Inc. (TXG)vs › | $10.54B | -7.29% | -12.03% | -16.66% | -21.79% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.61B | 16.09% | 11.90% | 0.02% | -3.56% |
ROA
1.4%
ROE
2.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 1.66% |
| 2024-12-31 | -0.90% |
| 2023-12-31 | 1.26% |
| 2022-12-31 | 7.35% |
| 2021-12-31 | 5.44% |
| 2020-12-31 | 3.15% |
| 2019-12-31 | 1.53% |
| 2018-12-31 | 11.92% |
| 2017-12-31 | 23.55% |
| 2016-12-31 | 4.04% |
| 2015-12-31 | 6.39% |
| 2014-12-31 | -12.49% |
| 2013-12-31 | 13.56% |
| 2012-12-31 | 14.59% |
| 2011-03-31 | -0.06% |
| 2010-03-31 | -5.69% |
| 2009-03-31 | 7.79% |
| 2008-03-31 | 53.90% |
| 2007-03-31 | -3.06% |
| 2006-03-31 | 2.44% |
| 2005-03-31 | -10.81% |
| 2004-03-31 | -32.25% |
| 2003-03-31 | -13.69% |
| 2002-03-31 | -15.32% |
| 2001-03-31 | -16.42% |
| 2000-03-31 | -10.52% |
| 1999-03-31 | -48.08% |
| 1998-03-31 | -14.04% |
| 1997-03-31 | -7.46% |
| 1996-03-31 | -201.75% |
